Skip to main content
Log in

Single breath exhaled nitric oxide in lung transplant patients: a preliminary clinical study

  • ORIGINAL ARTICLE
  • Published:
Transplant International

Abstract

Exhaled nitric oxide is considered as a marker of airway inflammation. We report here our preliminary experience with single-breath exhaled nitric oxide measured in lung transplant patients with and without bronchiolitis obliterans syndrome and in cardiac transplant patients. Peak and end-expiratory nitric oxide concentrations did not differ between groups, but single-breath exhaled nitric oxide recordings were strikingly different in patients suffering from bronchiolitis obliterans syndrome, with a slower decrease from peak to end-expiratory nitric oxide concentration. Further studies are required in order to determine whether theses abnormalities reflect the inflammatory process of bronchiolitis obliterans syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 10 July 1998 Received after revision: 11 March 1999 Accepted: 4 May 1999

About this article

Cite this article

Zegdi, R., Guillmain, R., Amrein, C. et al. Single breath exhaled nitric oxide in lung transplant patients: a preliminary clinical study. Transpl Int 12, 346–350 (1999). https://doi.org/10.1007/s001470050238

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001470050238

Navigation